Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Silicon Valley cancer diagnostics trailblazer, Guardant Health, is gearing up for an intense legal tussle as it appeals an adverse $83.4 million verdict handed down a day earlier in a high-stakes patent battle against a Seattle-based rival. Unanimous Blow in Wilmington, Delaware The seismic verdict, delivered in Wilmington, Delaware on Tuesday, concluded a gripping five-day